Form4insider filings, from the source

SEC Form 4 · accession 0000891293-15-000029

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Bruce J. Seeley
Officer — EVP, Chief Commercial Officer
Period of report
Jul 27, 2015
Accepted (ET)
Jul 29, 2015 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 27, 2015A300,000$0.00A300,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Performance RightsF2$0.00Jul 27, 2015A406,483A—Dec 31, 2016Common Stock406,483406,483D

Explanation of responses